NCT05777967View on ClinicalTrials.gov

Efficacy and Safety of FF-31501 in Meniscus Tear Patients

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Meniscus Injury
Interventions
BIOLOGICAL

human autologous synovial stem cells

A single injection of 1.5 to 9.0 x 10\^7 human autologous synovial stem cells under arthroscopy

Trial Locations (4)

Unknown

Medical corporation keimeikai Juko Osu hospital, Aichi

Wakamatsu Hospital of the University of OccupationalOC and Environmental Health, Fukuoka

Mie Prefectural General Medical Center, Mie

Tokyo Medical and Dental University Hospital, Tokyo

All Listed Sponsors
lead

FUJIFILM Toyama Chemical Co., Ltd.

INDUSTRY